On December 12, 2024, VJTBio Hangzhou Company's Year - End Thanksgiving and Animal Health Industry Cutting - Edge Dynamics Exchange was successfully held in Xiaoshan, Hangzhou. With the theme of "Gratitude for You, Accompanying All the Way," the meeting invited shareholders, investment institutions, partners, expert professors, and dealers of VJTBio in the Jiangsu - Zhejiang - Shanghai region. Everyone shared their insights and prospects for the future regarding the latest market dynamics, technological development trends, and innovative cooperation models in the domestic and international animal health industry. VJTBio hopes to unite the upstream and downstream enterprises in the animal innovative drug industry chain through its own efforts, and together build a win - win and healthy industrial ecosystem.

At the beginning of the meeting, Dr. Luo Haoshu, Chairman of VJTBio, reported to everyone the progress of various tasks of VJTBio in 2024 and conducted a systematic analysis of the global competition pattern of animal innovative drugs. Looking to the future, VJTBio will stay true to its original aspiration, continue to innovate, strengthen industrial linkage, firm up the confidence in development, and committed to making its own contributions to the high - quality development of the animal health industry. Subsequently, in the three round-table discussions, everyone had in-depth and lively discussions and exchanges on the key issues of the development of the animal health industry.

The first round - table discussion on "Market Dynamics and Trends of the Animal Health Industry" invited dealers of VJTBio 's breeding sector in East China, persons in charge of animal health enterprises, and deans of pet chain hospitals for full discussion. It is believed that China's animal health industry is in the period of transformation and upgrading, facing many challenges, but also harboring great development opportunities. In terms of products, although the market is broad, the proportion of innovative drugs targeting core pain points is still low, and most products are still in the homogeneous competition of generic drugs. In terms of services, customers' requirements for service quality and experience are increasing day by day. From R & D personnel closely meeting market demands for R & D innovation, to technical personnel providing full - process accompanying technical training, and then to product after - sales tracking services, it has become a higher standard faced by enterprises in the industry. VJTBio will remain committed to technological innovation and providing excellent services to inject strong momentum into the continuous development of the animal health industry.

In the second discussion on "Technological Innovation and Development under Market Demand," scientists and technical experts in the field of animal health new drug research and development had an in - depth discussion on the application of life health and medical new technologies in animal drug innovation. The experts shared their experiences in overcoming technical difficulties, analyzed market trends, and shared personal insights. These in - depth discussions not only revealed the key elements of industry development but also pointed out the pain points in the application of new technologies. The VJTBio team gained valuable insights from this exchange, which will serve as an important guide for future technological innovation and product development, helping to accurately grasp market dynamics and promote technological progress in the animal health field. We will translate these insights into concrete actions to ensure maintaining a leading position in the fierce market competition.

In the final discussion on "New Opportunities and Models for Industry Cooperation and Development," the guests focused on the emerging technologies and trends in the two industries of animal biologics and human innovative drugs, in - depth discussed the new opportunities contained in these trends, and how to seize these opportunities to strengthen cooperation within and outside the industry. The guests had a lively discussion on the new models of cooperation and shared several successful cases of industry cooperation. Through this series of wonderful sharing and in - depth discussion, everyone is more determined in their hope for the future development of the animal innovative drug industry and has a clearer strategic plan for the future development path.

After the Hangzhou meeting, some of the guests visited the Zhejiang production base of VJTBio for on-site inspection and exchange, personally experiencing and deeply understanding the production workshop and advanced production process of the first domestic animal recombinant protein antibody drug veterinary GMP production line.

By deeply analyzing the current market status of the global animal health industry and looking forward to its future trends, and sharing the latest developments of international cutting-edge technologies, VJTBio has demonstrated its continuous investment and unremitting exploration in the field of scientific and technological innovation. The company is committed to exploring the cooperation potential in the new era and actively contributing to the progress and development of the global animal health industry!